Should You Buy USANA Health Sciences, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, USANA Health Sciences, Inc. (USNA) carries a solid Quality of Company rating of 7.5/10. Trading at $14.90, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 8 of 11 CirclFi valuation models project upside for USANA Health Sciences, Inc. (USNA) at $14.90 — the model consensus leans bullish, with a Quality Score of 7.5/10 and Value-Trap risk of 45/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for USANA Health Sciences, Inc. (USNA) in 2026?
What Is the Bull Case vs the Bear Case for USANA Health Sciences, Inc. (USNA)?
| Bull case — $80.18 target (+438.1%) | Bear case — $1.07 target (-92.8%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, USANA Health Sciences, Inc.'s quality score of 7.5/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Value Trap algorithm, the stock shows moderate caution signals, meaning investors should verify that apparent undervaluation isn't masking declining business quality. |
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $14.90 and the median fair value of $28.79 implies +93.2% upside potential. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $1.07 (-92.8%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $80.18 (+438.1%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +530.9% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| Industry tailwind: geographic expansion could provide meaningful support for USANA Health Sciences, Inc.'s revenue and margin trajectory in the Packaged Foods space. | Industry headwind: e-commerce disruption represents a meaningful risk for USANA Health Sciences, Inc. and its Packaged Foods peers. |
How Does USNA Compare to Its Packaged Foods Peers?
Valuation data pages: MICC · DAR · JBS · INBP · LW · HLF · CYAN · ATPC · MAMA · PPC · JJSF
Which Other Stocks Score Like USNA on Quality?
Closest companies to USNA’s Quality of Company score of 7.5/10, across all industries.
- IHS — IHS Holding Limited (QOC 7.5) · analysis
- IMMR — Immersion Corporation (QOC 7.5) · analysis
- FNLC — The First Bancorp, Inc. (QOC 7.5) · analysis
- AOMR — Angel Oak Mortgage REIT, Inc. (QOC 7.5) · analysis
- INTR — Inter & Co, Inc. (QOC 7.5) · analysis
- BULL — Webull Corporation (QOC 7.5) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Packaged Foods Screens Does USNA Appear In?
So Is USANA Health Sciences, Inc. (USNA) Worth Buying in 2026?
The balance of evidence tilts cautiously positive for USANA Health Sciences, Inc. at $14.90. 8 of 11 models support upside to $28.79, backed by a 7.5/10 quality foundation. This is a "lean into, not load up on" setup in our framework.
These are quantitative model outputs, not investment recommendations. USANA Health Sciences, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About USNA Stock?
Should I buy USNA stock right now?
Based on CirclFi's multi-model analysis, 8 of 11 models see upside for USNA at $14.90. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.5/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in USANA Health Sciences, Inc.?
Key risks include: an elevated Value Trap score of 45/100, suggesting apparent undervaluation may mask deteriorating fundamentals; wide model disagreement (7387% spread), signaling high uncertainty; general market and sector-specific risks affecting Packaged Foods companies. Always diversify and consult a financial advisor.
How does USNA compare to its competitors?
Among Packaged Foods peers, USNA holds a Quality Score of 7.5/10. Comparable companies include MICC (QOC 7.5), DAR (QOC 7.5), JBS (QOC 7.5). The relative ranking helps investors identify whether USNA offers better fundamental quality than alternatives in the same sector.
Is USNA a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. USNA's Quality Score of 7.5/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy USNA at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $1.07 to $80.18. At $14.90, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for USNA.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad